Stay updated with breaking news from Clinical Programs Update. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aeterna Zentaris Provides Business Outlook and Outlines Pipeline Priorities - read this article along with other careers information, tips and advice on BioSpace
– Company advancing diversified portfolio focused on areas of significant unmet medical need – Supported by solid financial position with cash to fund…
– Company advancing diversified portfolio focused on areas of significant unmet medical need– Supported by solid financial position with cash to fund...
expected beyond 2023 CHARLESTON, S.C., May 05, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today reported its financial and operating results for the first quarter ended March 31, 2021. The Company also provided an update on its preclinical and clinical development programs. “Over the course of the first quarter, we continued to execute on our key strategic priorities by significantly st...
expected beyond 2023 CHARLESTON, S.C., May 05, 2021 (GLOBE NEWSWIRE) -- AEterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today reported its financial and operating results for the first quarter ended March 31, 2021. The Company also provided an update on its preclinical and clinical development programs. “Over the course of the first quarter, we continued to execute on our key strategic priorities by significantly stre...